Treatment with trkC agonist antibodies delays disease progression in neuromuscular degeneration ( nmd ) mice

Author: Ruiz Rocio  

Publisher: Oxford University Press

ISSN: 1460-2083

Source: Human Molecular Genetics, Vol.14, Iss.13, 2005-07, pp. : 1825-1837

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content